A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...
Identifying Health Information Technology Needs of Oncologists to Facilitate the Adoption of Genomic Medicine: Recommendations From the 2016 American Society of Clinical Oncology Omics and Precision ...
I think probably the best one is the urban patient who has access to an academic medical center that is running clinical ...
Medication adherence in clinical trials is hard to verify, but new technologies are fixing that. Discover why traditional methods fail and how cutting-edge tools are improving compliance monitoring.
DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of ...
Can a psychedelic drug with heavy side-effects and anecdotal evidence as a treatment for addiction become a wonder drug for ...
More flexibility in early-phase development for cell therapies is needed, a panel of US Food and Drug Administration (FDA) ...
Clinical trial names span a broad range, from straightforward acronyms to more inspiring titles—see: Eli Lilly’s optimistically dubbed family of Triumph trials—to the downright ostentatious, like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results